Data / Form D filings / Osteal Therapeutics, Inc.
Osteal Therapeutics, Inc.: Form D filings
Osteal Therapeutics, Inc., a pharmaceuticals company in Dallas, TX, filed 7 Form D notices with the SEC between 2018 and 2025. The latest, on November 5, 2025, reports $15.6 million sold of a $26.7 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4835 LYNDON B. JOHNSON FWY STE 635, Dallas, TX, 75244
- Phone
- (469) 809-2630
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1735936
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | New notice | $26,702,156 | $15,602,151 | $11,100,005 | 10 | Oct 17, 2025 | sec.gov |
| Jun 6, 2024 | New notice | $49,999,999 | $49,999,926 | $73 | 16 | May 22, 2024 | sec.gov |
| Sep 12, 2023 | New notice | $23,000,000 | $22,285,675 | $714,325 | 19 | Aug 29, 2023 | sec.gov |
| Dec 30, 2021 | New notice | $32,388,935 | $30,248,730 | $2,140,205 | 59 | Dec 17, 2021 | sec.gov |
| Jan 12, 2021 | Amendment | $2,000,000 | $2,000,000 | 25 | Nov 6, 2020 | sec.gov | |
| Nov 23, 2020 | New notice | $2,000,000 | $1,465,000 | $535,000 | 17 | Nov 6, 2020 | sec.gov |
| Apr 6, 2018 | New notice | $7,782,690 | $7,412,261 | $370,429 | 45 | Mar 26, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Martin Sands | Director | |
| Judson Cooper | Director | |
| Brian de Beaubien | Executive Officer, Director | |
| David Thompson | Executive Officer, Director | |
| Biren Mehta | Director | |
| Douglas Kohrs | Director | |
| David Cash | Director | |
| Rushu Luo | Director | |
| Erik Oros | Director | |
| Sonal Patel | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Osteal Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.